Notice Number: NOT-NS-16-030

Key Dates
Release Date: June 1, 2016

Issued by
National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute of Neurological Disorders and Stroke (NINDS) will participate, effective immediately, in PAR-16-183, “Limited Competition: Rare Diseases Clinical Research Network (RDCRN) Project Supplements for Clinical Trials to Repurpose Drugs in Collaboration with E-RARE Awardees (Admin Supp)".

The following sections have been updated to reflect the participation of NINDS in this PAR:

Part 1. Overview Information

Components of Participating Organizations
National Heart, Lung, and Blood Institute (NHLBI)
National Center for Advancing Translational Sciences (NCATS)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Allergy and Infectious Diseases (NIAID) 
National Institute of Neurological Disorders and Stroke (NINDS)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.350, 93.855, 93.856, 93.847, 93.846, 93.837, 93.838, 93.839, 93.233, 93.840, 93.853

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Jill Morris
Program Director, NINDS
Telephone: 301-496-5745
Email: jill.morris@nih.gov